Oxidized low-density lipoprotein increases the proliferation and migration of human coronary artery smooth muscle cells through the upregulation of osteopontin

Liu,Jun; Ren,Yingang; Kang,Li; Zhang,Lihua

doi:10.3892/ijmm.2014.1681

Oxidized low-density lipoprotein increases the proliferation and migration of human coronary artery smooth muscle cells through the upregulation of osteopontin

Authors:
- Jun Liu
- Yingang Ren
- Li Kang
- Lihua Zhang
View Affiliations

Affiliations: Department of Geriatrics, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shaanxi 710038, P.R. China
Published online on: February 28, 2014 https://doi.org/10.3892/ijmm.2014.1681
Pages: 1341-1347

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Smooth muscle cell (SMC) proliferation and migration are known to play a critical role in the development of atherosclerosis. Oxidized low-density lipoprotein (oxLDL) is involved in the generation of atherosclerotic lesions. Recent studies have indicated that oxLDL is a well-established risk factor for atherosclerosis that induces vascular smooth muscle cell (VSMC) proliferation and migration; however, the exact mechanisms involved have not been fully elucidated. In this study, the proliferation of human coronary artery smooth muscle cells (HCASMCs) was detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Cell migration was determined by Transwell assay. Osteopontin (OPN), matrix metaloproteinase-9 (MMP‑9) and αvβ3 integrin expression were measured by mRNA and western blot analysis. OPN and MMP‑9 knockdown cells were established through transfection with OPN siRNA or MMP‑9 siRNA, respectively. Our results revealed that oxLDL makredly promoted HCASMC proliferation and migration in a dose‑dependent manner. Further experiments demonstrated that oxLDL upregulated the expression of OPN and oxLDL. Cell proliferation and migration were markedly reduced following the knockdown of the OPN gene in the HCASMCs. We then found that treatment with oxLDL induced a concentration-dependent increase in MMP‑9 mRNA and protein levels in the HCASMCs. These effects were partially abrogated by silencing OPN expression or blocking the αvβ3 integrin pathway. Moreover, cells treated with MMP‑9 siRNA or αvβ3 antibody showed lower proliferation and migration rates. This study provides direct in vitro evidence that the exposure of HCASMCs to oxLDL induces the activation of OPN, leading to higher protein levels of MMP‑9, and to an increased proliferation and migration of HCASMCs.

View Figures

View References

1	Wang XH, Wang F, You SJ, et al: Dysregulation of cystathionine γ-lyase (CSE)/hydrogen sulfide pathway contributes to ox-LDL-induced inflammation in macrophage. Cell Signal. 25:2255–2262. 2013.
2	Glass CK and Witztum JL: Atherosclerosis: the road ahead. Cell. 104:503–516. 2001. View Article : Google Scholar : PubMed/NCBI
3	González-Navarro H, Abu Nabah YN, Vinué Á, et al: p19(ARF) deficiency reduces macrophage and vascular smooth muscle cell apoptosis and aggravates atherosclerosis. J AM Coll Cardiol. 55:2258–2268. 2010.PubMed/NCBI
4	Gerthoffer WT: Mechanisms of vascular smooth muscle cell migration. Circ Res. 100:607–621. 2007. View Article : Google Scholar : PubMed/NCBI
5	Murry CE, Gipaya CT, Bartosek T, Benditt EP and Schwartz SM: Monoclonality of smooth muscle cells in human atherosclerosis. Am J Pathol. 151:697–705. 1997.PubMed/NCBI
6	Johnson JL, Dwivedi A, Somerville M, George SJ and Newby AC: Matrix metalloproteinase (MMP)-3 activates MMP-9 mediated vascular smooth muscle cell migration and neointima formation in mice. Arterioscl Thromb Vas. 31:e35–e44. 2011. View Article : Google Scholar : PubMed/NCBI
7	Li LX, Zhang XF, Bai X and Tong Q: SDF-1 promotes ox-LDL induced vascular smooth muscle cell proliferation. Cell Biol Int. 37:988–994. 2013. View Article : Google Scholar : PubMed/NCBI
8	Ross R: The pathogenesis of atherosclerosis - an update. New Engl J Med. 314:488–500. 1986. View Article : Google Scholar : PubMed/NCBI
9	Clarke MC, Figg N, Maguire JJ, et al: Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat Med. 12:1075–1080. 2006. View Article : Google Scholar : PubMed/NCBI
10	Bennett MR and Boyle JJ: Apoptosis of vascular smooth muscle cells in atherosclerosis. Atherosclerosis. 138:3–9. 1998. View Article : Google Scholar : PubMed/NCBI
11	Mazière C, Gomila C and Mazière JC: Oxidized low-density lipoprotein increases osteopontin expression by generation of oxidative stress. Free Radical Bio Med. 48:1382–1387. 2010.PubMed/NCBI
12	Cho HJ, Cho HJ and Kim HS: Osteopontin: a multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification. Curr Atheroscler Rep. 11:206–213. 2009. View Article : Google Scholar : PubMed/NCBI
13	Giachelli CM, Lombardi D, Johnson RJ, Murry CE and Almeida M: Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol. 152:353–358. 1998.PubMed/NCBI
14	Weber GF, Zawaideh S, Hikita S, Kumar VA, Cantor H and Ashkar S: Phosphorylation-dependent interaction of osteopontin with its receptors regulates macrophage migration and activation. J Leukocyte Biol. 72:752–761. 2002.PubMed/NCBI
15	Koh A, Da Silva AP, Bansal AK, et al: Role of osteopontin in neutrophil function. Immunology. 122:466–475. 2007. View Article : Google Scholar : PubMed/NCBI
16	Ikeda T, Shirasawa T, Esaki Y, Yoshiki S and Hirokawa K: Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta. J Clin Invest. 92:2814–2820. 1993. View Article : Google Scholar : PubMed/NCBI
17	Zohar R, Suzuki N, Suzuki K, et al: Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration. J Cell Physiol. 184:118–130. 2000. View Article : Google Scholar : PubMed/NCBI
18	Shannon KE, Keene JL, Settle SL, et al: Anti-metastatic properties of RGD-peptidomimetic agents S137 and S247. Clin Exp Metastasis. 21:129–138. 2004. View Article : Google Scholar : PubMed/NCBI
19	Chen YJ, Wei YY, Chen HT, et al: Osteopontin increases migration and MMP-9 up-regulation via αvβ3 integrin, FAK, ERK, and NF-κB-dependent pathway in human chondrosarcoma cells. J Cell Physiol. 221:98–108. 2009.PubMed/NCBI
20	Newby AC: Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates. Cardiovasc Res. 69:614–624. 2006. View Article : Google Scholar
21	Johnson C and Galis ZS: Matrix metalloproteinase-2 and -9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization. Arterioscl Thromb Vasc Biol. 24:54–60. 2004. View Article : Google Scholar : PubMed/NCBI
22	Kuzuya M, Kanda S, Sasaki T, et al: Deficiency of gelatinase a suppresses smooth muscle cell invasion and development of experimental intimal hyperplasia. Circulation. 108:1375–1381. 2003. View Article : Google Scholar : PubMed/NCBI
23	Johnson JL, George SJ, Newby AC and Jackson CL: Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries. Proc Natl Acad Sci USA. 102:15575–15580. 2005. View Article : Google Scholar : PubMed/NCBI
24	Belcher J, Egan JO, Bridgman G, Baker R and Flack JM: A micro-enzymatic method to measure cholesterol and triglyceride in lipoprotein subfractions separated by density gradient ultracentrifugation from 200 microliters of plasma or serum. J Lipid Res. 32:359–370. 1991.
25	Feng X, Zhang Y, Xu R, et al: Lipopolysaccharide up-regulates the expression of Fcalpha/mu receptor and promotes the binding of oxidized low-density lipoprotein and its IgM antibody complex to activated human macrophages. Atherosclerosis. 208:396–405. 2010. View Article : Google Scholar : PubMed/NCBI
26	Lowry OH, Rosebrough NJ, Farr AL and Randall RJ: Protein measurement with the Folin phenol reagent. J biol Chem. 193:265–275. 1951.PubMed/NCBI
27	Shyu KG, Chen SC, Wang BW, Cheng WP and Hung HF: Mechanism of the inhibitory effect of atorvastatin on leptin expression induced by angiotensin II in cultured human coronary artery smooth muscle cells. Clin Sci (Lond). 122:33–42. 2012. View Article : Google Scholar
28	Pellet-Many C, Frankel P, Evans IM, Herzog B, Jünemann-Ramirez M and Zachary IC: Neuropilin-1 mediates PDGF stimulation of vascular smooth muscle cell migration and signalling via p130Cas. Biochem J. 435:609–618. 2011. View Article : Google Scholar : PubMed/NCBI
29	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
30	Aikawa M, Rabkin E, Okada Y, et al: Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation. 97:2433–2444. 1998. View Article : Google Scholar
31	Rangaswami H and Kundu GC: Osteopontin stimulates melanoma growth and lung metastasis through NIK/MEKK1-dependent MMP-9 activation pathways. Oncol Rep. 18:909–915. 2007.PubMed/NCBI
32	Wai PY and Kuo PC: Osteopontin: regulation in tumor metastasis. Cancer Metastasis Rev. 27:103–118. 2008. View Article : Google Scholar : PubMed/NCBI
33	Doran AC, Meller N and McNamara CA: Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol. 28:812–819. 2008. View Article : Google Scholar : PubMed/NCBI
34	Lusis AJ: Atherosclerosis. Nature. 407:233–241. 2000. View Article : Google Scholar : PubMed/NCBI
35	Augé N, Maupas-Schwalm F, Elbaz M, et al: Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation. Circulation. 110:571–578. 2004.
36	Ricciarelli R, Zingg JM and Azzi A: Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells. Circulation. 102:82–87. 2000. View Article : Google Scholar : PubMed/NCBI
37	Auge N, Garcia V, Maupas-Schwalm F, Levade T, Salvayre R and Negre-Salvayre A: Oxidized LDL-induced smooth muscle cell proliferation involves the EGF receptor/PI-3 kinase/Akt and the sphingolipid signaling pathways. Arterioscl Thromb Vasc Biol. 22:1990–1995. 2002. View Article : Google Scholar : PubMed/NCBI
38	Witztum JL and Steinberg D: The oxidative modification hypothesis of atherosclerosis: does it hold for humans? Trends Cardiovas Med. 11:93–102. 2001. View Article : Google Scholar : PubMed/NCBI